Starpharma (Australia)

Institution (Company)

Homepage ROR

Also Known As

Starpharma (Australia)

Publications

17.4K

Citations

Authors

Concepts

About

Starpharma (Australia) is a company institution in Melbourne, Australia known for medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	86	6.6K
2	Engineering	6	19	2.3K
3	Natural Sciences	4	8	289
4	Health Sciences	1	1	13
5	Allergy	1	4	104

Starpharma (Australia)

Publications

17.4K

Citations

Page 1

	Year	Citations
Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy Lisa M. Kaminskas, Victoria M. McLeod, Gemma M. Ryan, Journal of Controlled Release Cancer TherapyLung MetastasesOncologyPolymer-drug ConjugatePharmacology	2014	187
The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly <scp>l</scp>-Lysine Dendrimers Lisa M. Kaminskas, Ben J. Boyd, Peter Karellas, Molecular Pharmaceutics Pharmaceutical ScienceEngineeringSystemic PharmacokineticsLarger DendrimersPeg Chain Length	2008	174
Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity David Tyssen, Scott Henderson, Adam Johnson, PLoS ONE	2010	171
SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans Clare F. Price, David Tyssen, Secondo Sonza, PLoS ONE	2011	171
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems Lisa M. Kaminskas, Victoria M. McLeod, Brian D. Kelly, Nanomedicine Nanotechnology Biology and Medicine NanomedicineAntitumor ActivityPolymer-drug ConjugateMedicineDrug Delivery Systems	2011	168
Polyanionic (i.e., Polysulfonate) Dendrimers Can Inhibit the Replication of Human Immunodeficiency Virus by Interfering with Both Virus Adsorption and Later Steps (Reverse Transcriptase/Integrase) in the Virus Replicative Cycle Myriam Witvrouw, Valery Fikkert, Wim Pluymers, Molecular Pharmacology	2000	161
Cationic Poly- <scp>l</scp> -lysine Dendrimers: Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats Ben J. Boyd, Lisa M. Kaminskas, Peter Karellas, Molecular Pharmaceutics	2006	159
PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats Lisa M. Kaminskas, Jagannath Kota, Victoria M. McLeod, Journal of Controlled Release Sc AdministrationPharmaceutical ScienceDrug TargetingPolylysine DendrimersPolymer-drug Conjugate	2009	144
Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-<scp>l</scp>-lysine Dendrimers Lisa M. Kaminskas, Brian D. Kelly, Victoria M. McLeod, Molecular Pharmaceutics Dendrimer DispositionNanomedicinePharmaceutical ScienceDrug TargetingTumor Disposition	2009	139
Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker Lisa M. Kaminskas, Brian D. Kelly, Victoria M. McLeod, Journal of Controlled Release NanomedicineMedicinal ChemistryPegylated Polylysine DendrimersEngineeringDrug Targeting	2011	132

Page 1